825
Views
27
CrossRef citations to date
0
Altmetric
Brief Communication

Acute behavioural disturbance associated with phenibut purchased via an internet supplier

, , , , &
Pages 636-638 | Received 16 Mar 2015, Accepted 01 Jun 2015, Published online: 26 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Pieter A. Cohen, Ross R. Ellison, John C. Travis, Slava V. Gaufberg & Roy Gerona. (2022) Quantity of phenibut in dietary supplements before and after FDA warnings. Clinical Toxicology 60:4, pages 486-488.
Read now
Kirsten E. Smith, Jeffery M. Rogers, Justin C. Strickland & David H. Epstein. (2021) When an obscurity becomes trend: social-media descriptions of tianeptine use and associated atypical drug use. The American Journal of Drug and Alcohol Abuse 47:4, pages 455-466.
Read now
Torben Breindahl, Peter Hindersson & Andreas Kimergård. (2020) New psychoactive substances (NPS) escape routine drug testing: a case report of phenibut. Toxicology Communications 4:1, pages 55-58.
Read now

Articles from other publishers (23)

E. V. Kostenko, A. G. Kashezhev, L. M. Petrova & M. A. Eneeva. (2023) Medical support of rehabilitation of stroke patients: the role of GABA-ergic drugs. Meditsinskiy sovet = Medical Council:21, pages 8-19.
Crossref
Robin Martin, Ilana Buffenstein, Daniel Cho & Miki Kiyokawa. (2023) Toxidrome of an Easily Obtainable Nootropic. Journal of Clinical Psychopharmacology 43:6, pages 507-510.
Crossref
Michael Sahagian, Alicia Mastrocco & Jennifer Prittie. (2023) Phenibut toxicosis in a dog. Journal of Veterinary Emergency and Critical Care 33:4, pages 472-476.
Crossref
Jeremy Weleff, Alexsandra Kovacevich, Jesse Burson, Neil Nero & Akhil Anand. (2023) Clinical Presentations and Treatment of Phenibut Toxicity and Withdrawal: A Systematic Literature Review. Journal of Addiction Medicine 17:4, pages 407-417.
Crossref
Amber Patt, Haley Fox, Lauren Wells, Jillian Theobald & Ryan Feldman. (2023) Seizure Occurring During Baclofen Monotherapy for Phenibut Withdrawal. Clinical Neuropharmacology 46:2, pages 79-81.
Crossref
Daniel Komisarek, Takin Haj Hassani Sohi & Vera Vasylyeva. (2022) Co-crystals of zwitterionic GABA API's pregabalin and phenibut: properties and application. CrystEngComm 24:48, pages 8390-8398.
Crossref
Crystal Arndt & Teresa R Gray. (2022) Phenibut, a GABAB Agonist, Detected in a Fatality. Journal of Analytical Toxicology 46:2, pages e73-e77.
Crossref
Monique MunAndrew Wong. (2020) Kratom and Phenibut: A Concise Review for Psychiatric Trainees. American Journal of Psychiatry Residents' Journal 16:2, pages 6-8.
Crossref
Ellen M. F. Strömmer, Wendy Leith, Maurice P. Zeegers & Michael D. Freeman. (2020) The role of restraint in fatal excited delirium: a research synthesis and pooled analysis. Forensic Science, Medicine and Pathology 16:4, pages 680-692.
Crossref
Einars Kupats, Jelena Vrublevska, Baiba Zvejniece, Edijs Vavers, Gundega Stelfa, Liga Zvejniece & Maija Dambrova. (2020) Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports. Pharmacopsychiatry 53:05, pages 201-208.
Crossref
Katherine Z Isoardi, Sanjeewa Kulawickrama & Geoffrey K Isbister. (2019) Severe phenibut poisoning: An adolescent case cluster. Journal of Paediatrics and Child Health 56:2, pages 330-331.
Crossref
Daniel J. McCabe, Stacey A. Bangh, Ann M. Arens & Jon B. Cole. (2019) Phenibut exposures and clinical effects reported to a regional poison center. The American Journal of Emergency Medicine 37:11, pages 2066-2071.
Crossref
Nadia C.B. Coenen, Boukje A.G. Dijkstra, Albert Batalla & Arnt F.A. Schellekens. (2019) Detoxification of a Patient With Comorbid Dependence on Phenibut and Benzodiazepines by Tapering With Baclofen. Journal of Clinical Psychopharmacology 39:5, pages 511-514.
Crossref
Edward A. Jouney. (2019) Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable “Dietary Supplement” With Propensities for Physical Dependence and Addiction. Current Psychiatry Reports 21:4.
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Kenichi Tamama & Michael J. Lynch. 2020. Substance Use Disorders. Substance Use Disorders 463 502 .
Philippe Gonin, Nicolas Beysard, Bertrand Yersin & Pierre‐Nicolas Carron. (2017) Excited Delirium: A Systematic Review. Academic Emergency Medicine 25:5, pages 552-565.
Crossref
Marie Claire Van Hout. (2018) A narrative review of the naturally occurring inhibitory neurotransmitter gamma-aminobutyric acid (GABA) called phenibut in dietary supplements. Performance Enhancement & Health 6:1, pages 33-35.
Crossref
William Li & Bhaskara Madhira. (2017) Phenibut (β-Phenyl-γ-Aminobutyric Acid) Psychosis. American Journal of Therapeutics 24:5, pages e639-e640.
Crossref
Yash B. Joshi, Samantha F. Friend, Berenice Jimenez & Louisa R. Steiger. (2017) Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut. Journal of Clinical Psychopharmacology 37:4, pages 478-480.
Crossref
Seth Sankary, Peter Canino & Jennifer Jackson. (2017) Phenibut overdose. The American Journal of Emergency Medicine 35:3, pages 516.e1-516.e2.
Crossref
Cristian Merchan. (2016) Phenibut Overdose in Combination with Fasoracetam: Emerging Drugs of Abuse. Journal of Clinical Intensive Care and Medicine, pages 001-004.
Crossref
David R. Owen, David M. Wood, John R. H. Archer & Paul I. Dargan. (2016) Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review 35:5, pages 591-596.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.